Home > Healthcare > Analytical Instruments > Molecular Analysis > PCR Technologies Market

PCR Technologies Market Size

  • Report ID: GMI5551
  • Published Date: May 2024
  • Report Format: PDF

PCR Technologies Market Size

PCR Technologies Market size was valued at around USD 14.4 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032. PCR (Polymerase Chain Reaction) technologies refer to a collection of methods used to amplify, or make many copies of, a specific DNA sequence. This technique allows scientists to produce millions to billions of copies of a particular DNA segment from a very small initial sample.

 

The escalating prevalence of infectious diseases and genetic disorders underscores the growing necessity for PCR technologies. Citing the World Health Organization (WHO), genetic disorders and congenital abnormalities affect approximately 2%-5% of all live births, contributing to up to 30% of pediatric hospital admissions and around 50% of childhood fatalities in industrialized nations. Therefore, as these conditions become more prevalent, the demand for PCR-based tests is expected to rise. These tests are essential for rapidly and accurately identifying pathogens and genetic mutations, facilitating timely diagnosis, treatment, and optimal disease management.
 

Furthermore, PCR has undergone significant advancements over the years, leading to the development of faster, more sensitive, and highly efficient PCR techniques. These advancements include real-time PCR, digital PCR, and multiplex PCR, among others. Each iteration brings improvements in speed, accuracy, and the ability to detect multiple targets simultaneously, thus widening its applications in diagnostics and research.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

PCR technologies market size was USD 14.4 billion in 2023 and is expected to register 8.1% CAGR from 2024-2032 owing to the escalating prevalence of infectious diseases and genetic disorders worldwide.

PCR technologies industry from the kits & reagents segment and is expected to reach USD 11.6 billion by 2032 due to the rising demand for accurate molecular diagnostic tests, particularly in infectious diseases and oncology.

The U.S. PCR technologies industry is expected to record USD 10.4 billion by 2032 due to increased investment in biomedical research, significantly supported by government funding initiatives and grants in the region.

Danaher Corporation, Eppendorf SE, F. Hoffmann-LA Roche Ltd., Illumina, Inc., Merck KGaA, New England Biolabs, Promega Corporation, QIAGEN N.V., Standard Biotools Inc., Takara Holdings Inc., and Thermo Fisher Scientific Inc., are some of the major PCR technologies companies worldwide.

PCR Technologies Market Scope

Buy Now


Premium Report Details

  • Base Year: 2021
  • Companies covered: 15
  • Tables & Figures: 374
  • Countries covered: 23
  • Pages: 207
 Download Free Sample